{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:09:38Z","timestamp":1789877378839,"version":"4.0.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,12]],"date-time":"2016-10-12T00:00:00Z","timestamp":1476230400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,10,12]],"date-time":"2016-10-12T00:00:00Z","timestamp":1476230400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["1 UL1 RR023150"],"award-info":[{"award-number":["1 UL1 RR023150"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50-CA01508"],"award-info":[{"award-number":["P50-CA01508"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA 90297052"],"award-info":[{"award-number":["CA 90297052"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mayo Clinic Office of Health Disparities Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s00277-016-2842-4","type":"journal-article","created":{"date-parts":[[2016,10,11]],"date-time":"2016-10-11T22:59:23Z","timestamp":1476226763000},"page":"51-55","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence of BCL-2\/J(H) Translocation in Healthy African Americans"],"prefix":"10.1007","volume":"96","author":[{"given":"Gerardo","family":"Colon-Otero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Van Wier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg J.","family":"Ahmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Braggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica L.","family":"Albertie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Weis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sikander","family":"Ailawadhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Cerhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Vishnu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Jorgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Foran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen S.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,12]]},"reference":[{"key":"2842_CR1","volume-title":"Non-Hodgkin lymphoma","author":"SEER Cancer Statistics Factsheets","year":"2016","unstructured":"SEER Cancer Statistics Factsheets (2016) Non-Hodgkin lymphoma. National Cancer Institute, Bethesda, Available at: \n                    http:\/\/seer.cancer.gov\/statfacts\/html\/nhl.html\n                    \n                  . Accessed July 19, 2016"},{"key":"2842_CR2","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1172\/JCI63186","volume":"122","author":"R Kridel","year":"2012","unstructured":"Kridel R, Sehn LH, Gascoyne RD (2012) Pathogenesis of follicular lymphoma. J Clin Invest 122:3424\u20133431","journal-title":"J Clin Invest"},{"key":"2842_CR3","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","volume":"17","author":"JJ van Dongen","year":"2003","unstructured":"van Dongen JJ, Langerak AW, Br\u00fcggemann M et al (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17:2257\u20132317","journal-title":"Leukemia"},{"key":"2842_CR4","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/bjh.12659","volume":"16","author":"D Chihara","year":"2014","unstructured":"Chihara D, Ito H, Matsuda T et al (2014) Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol 16:536\u2013545","journal-title":"Br J Haematol"},{"key":"2842_CR5","first-page":"393","volume":"60","author":"CR Flowers","year":"2010","unstructured":"Flowers CR, Sinha R, Vose JM (2010) Improving outcomes for patients with diffuse large B-cell lymphoma. CA Cancer J Clin 60:393\u2013408","journal-title":"CA Cancer J Clin"},{"key":"2842_CR6","doi-asserted-by":"publisher","first-page":"8910","DOI":"10.1073\/pnas.91.19.8910","volume":"91","author":"Y Liu","year":"1994","unstructured":"Liu Y, Hernandez AM, Shibata D, Cortopassi GA (1994) BCL2 translocation frequency rises with age in humans. Proc Natl Acad Sci USA 91:8910\u20138914","journal-title":"Proc Natl Acad Sci USA"},{"key":"2842_CR7","first-page":"2876","volume":"55","author":"W Ji","year":"1995","unstructured":"Ji W, Qu GZ, Ye P, Zhang XY, Halabi S, Ehrlich M (1995) Frequent detection of bcl-2\/JH translocations in human blood and organ samples by a quantitative polymerase chain reaction assay. Cancer Res 55:2876\u20132882","journal-title":"Cancer Res"},{"key":"2842_CR8","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1182\/blood.V98.2.486","volume":"98","author":"M Yasukawa","year":"2001","unstructured":"Yasukawa M, Bando S, D\u00f6lken G et al (2001) Low frequency of BCL-2\/J(H) translocation in peripheral blood lymphocytes of healthy Japanese individuals. Blood 98:486\u2013488","journal-title":"Blood"},{"key":"2842_CR9","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1200\/JCO.2013.52.8190","volume":"32","author":"S Roulland","year":"2014","unstructured":"Roulland S, Kelly RS, Morgado E et al (2014) t(14, 18) translocation: A predictive blood biomarker for follicular lymphoma. J Clin Oncol 32:1347\u20131355","journal-title":"J Clin Oncol"},{"key":"2842_CR10","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/cncr.23201","volume":"112","author":"G Colon-Otero","year":"2008","unstructured":"Colon-Otero G, Smallridge RC, Solberg LA Jr et al (2008) Disparities in participation in cancer clinical trials in the United States : a symptom of a healthcare system in crisis. Cancer 112:447\u2013454","journal-title":"Cancer"},{"key":"2842_CR11","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s13187-011-0288-x","volume":"27","author":"G Colon-Otero","year":"2012","unstructured":"Colon-Otero G, Albertie M, Lesperance M et al (2012) A pilot program in collaboration with African American churches successfully increases awareness of the importance of cancer research and participation in cancer translational research studies among African Americans. J Cancer Educ 27:294\u2013298","journal-title":"J Cancer Educ"},{"key":"2842_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.canep.2014.12.001","volume":"39","author":"Y Li","year":"2015","unstructured":"Li Y, Wang Y, Wang Z, Yi D, Ma S (2015) Racial differences in three major NHL subtypes: descriptive epidemiology. Cancer Epidemiol 39:8\u201313","journal-title":"Cancer Epidemiol"},{"key":"2842_CR13","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1182\/blood-2012-07-443606","volume":"121","author":"A Baker","year":"2013","unstructured":"Baker A, Braggio E, Jacobus S et al (2013) Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approach. Blood 121:3147\u20133152","journal-title":"Blood"},{"key":"2842_CR14","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1200\/JCO.2001.19.2.420","volume":"19","author":"KE Summers","year":"2001","unstructured":"Summers KE, Goff LK, Wilson AG, Gupta RK, Lister TA, Fitzgibbon J (2001) Frequency of the Bcl-2\/IgH rearrangement in normal individuals: Implications for the monitoring of disease in patients with follicular lymphoma. J Clin Oncol 19:420\u2013424","journal-title":"J Clin Oncol"},{"key":"2842_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/jncimonographs\/lgn005","volume":"39","author":"G Dolken","year":"2008","unstructured":"Dolken G, Dolken L, Hirt C, Fusch C, Rabkin CS, Schuler F (2008) Age-dependent prevalence and frequency of circulating t(14;18)-positive cells in the peripheral blood of healthy individuals. J Natl Cancer Inst Monogr 39:44\u201347","journal-title":"J Natl Cancer Inst Monogr"},{"key":"2842_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00277-009-0755-1","volume":"89","author":"M Nambiar","year":"2010","unstructured":"Nambiar M, Raghavan SC (2010) Prevalence and analysis of t(14;18) and t(11;14) chromosomal translocations in healthy Indian population. Ann Hematol 89:35\u201343","journal-title":"Ann Hematol"},{"key":"2842_CR17","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.3109\/10428194.2013.788177","volume":"54","author":"C Hirt","year":"2013","unstructured":"Hirt C, Weitmann K, Schuler F et al (2013) Circulating t(14;18)-positive cells in healthy individuals: association with age and sex but not with smoking. Leuk Lymphoma 54:2679\u20132684","journal-title":"Leuk Lymphoma"},{"key":"2842_CR18","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.leukres.2005.10.001","volume":"30","author":"C Schmitt","year":"2006","unstructured":"Schmitt C, Balogh B, Grundt A et al (2006) The bcl-2\/IgH rearrangement in a population of 204 healthy individuals: occurrence, age and gender distribution, breakpoints, and detection method validity. Leuk Res 30:745\u2013750","journal-title":"Leuk Res"},{"key":"2842_CR19","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.3324\/haematol.2008.001495","volume":"93","author":"G Ott","year":"2008","unstructured":"Ott G, Rosenwald A (2008) Molecular pathogenesis of follicular lymphoma. Haematologica 93:1773\u20131776","journal-title":"Haematologica"},{"key":"2842_CR20","doi-asserted-by":"publisher","first-page":"530","DOI":"10.2353\/jmoldx.2007.070038","volume":"9","author":"OK Weinberg","year":"2007","unstructured":"Weinberg OK, Ali WZ, Mariappan MR, Shum C, Levy R, Arber DA (2007) \u201cMinor\u201d BCL2 breakpoints in follicular lymphoma: frequency and correlation with grade and disease, presentation in 236 cases. J Mol Diagn 9:530\u2013537","journal-title":"J Mol Diagn"},{"key":"2842_CR21","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/S1470-2045(16)30019-5","volume":"17","author":"S Stilgenbauer","year":"2016","unstructured":"Stilgenbauer S, Eichhorst B, Schetelig J et al (2016) Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study. Lancet Oncol 17:768\u2013778","journal-title":"Lancet Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-016-2842-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-016-2842-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-016-2842-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T11:11:50Z","timestamp":1589627510000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-016-2842-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,12]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["2842"],"URL":"https:\/\/doi.org\/10.1007\/s00277-016-2842-4","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,12]]},"assertion":[{"value":"31 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This project was part of a Mayo Clinic Institutional Review Board-approved translational cancer research pilot study aimed at increasing awareness on the importance of cancer research among the Northeast Florida AA population.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Colon-Otero discloses research funding with Novartis pharmaceuticals. Dr. Alawadhi discloses that he is a consultant for Novartis, Amgen, Pharmacyclics, and Takeda pharmaceuticals. Dr. Fonseca has received a patent for the prognostication of MM based on genetic categorization by FISH of the disease. He has a patent application pending for the use of calcium isotopes as biomarkers for bone metabolisms (primary site and investigators, Arizona State University). He has received consulting fees from Celgene, BMS, Bayer, Novartis, Sanofi, Janssen, Millennium, a Takeda Company, and AMGEN. He is also a member of the Scientific Advisory Board of Applied Biosciences.Mr. Van Wier, Mr. Ahmann, Dr. Braggio, Ms. Albertie, Ms. Weis, Dr. Cerhan, Dr. Vishnu, Mr. Jorgensen, Dr. Foran, and Ms. Thomas declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This paper was funded by the Mayo Clinic Office of Health Disparities Research, Mayo Clinic CTSA grant (NCRR\/NIH Grant Number 1 UL1 RR024150), the Mayo Clinic Cancer Center (NCI grant number P50-CA01508), and Active SPORE CA 90297052 grant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study Funding"}},{"value":"This paper was presented at AACR Cancer Disparities Meeting, Atlanta, GA, USA, 2015.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Previous Presentations"}}]}}